Brief: ExeVir, Mithra Announce Manufacturing Collaboration For Innovative COVID-19 Treatments

Mithra Pharmaceuticals SA

15/07/2021 06:50

July 15 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * EXEVIR AND MITHRA ANNOUNCE MANUFACTURING COLLABORATION FOR
ACCELERATED CLINICAL DEVELOPMENT OF EXEVIR'S NOVEL LLAMA-DERIVED
ANTIBODY THERAPIES FOR POTENTIAL TREATMENT AND PREVENTION OF
COVID-19
    * JOINT UNIQUE EXPERTISE OF TWO BELGIAN BIOTECHS TO PROVIDE
GLOBAL
ACCESS TO INNOVATIVE THERAPIES FOR A BROAD RANGE OF
CORONAVIRUSES, INCLUDING VARIANTS OF CONCERN
    * MANUFACTURING OF EXEVIR'S CANDIDATE PRODUCT AT MITHRA
CDMO'S NEW
INJECTABLE FACILITY

Source text for Eikon:  ID:nPreZWdlra 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))